Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy is a research paper published in Human Molecular Genetics (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: MDA238981
National Institutes of Health
Grant: MDA628561
National Institutes of Health
Grant: R01AR064338-01A1
NIAMS NIH HHS
Grant: R01 AR064338
National Institutes of Health
Grant: 5R01AR064338-05
Laminin protein therapy for Congenital Muscular Dystrophy
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals